These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8159859)
1. Ticlopidine hydrochloride: its current use in cerebrovascular disease. Bronstein KS; Chadwick LR Rehabil Nurs; 1994; 19(1):17-20. PubMed ID: 8159859 [TBL] [Abstract][Full Text] [Related]
2. Stroke prevention in women: role of aspirin versus ticlopidine. Hershey LA Am J Med; 1991 Sep; 91(3):288-92. PubMed ID: 1832517 [TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy in the treatment of cerebrovascular disease. Couch JR Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382 [TBL] [Abstract][Full Text] [Related]
4. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents. Jamieson DG; Parekh A; Ezekowitz MD J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203 [TBL] [Abstract][Full Text] [Related]
6. Ticlopidine: a new antiplatelet agent for the secondary prevention of stroke. Murray JC; Kelly MA; Gorelick PB Clin Neuropharmacol; 1994 Feb; 17(1):23-31. PubMed ID: 8149356 [TBL] [Abstract][Full Text] [Related]
7. Role of ticlopidine for prevention of stroke. Albers GW Stroke; 1992 Jun; 23(6):912-6. PubMed ID: 1595115 [TBL] [Abstract][Full Text] [Related]
8. Ticlopidine hydrochloride and prevention of stroke. Macko R West J Med; 1993 Aug; 159(2):182. PubMed ID: 8212686 [No Abstract] [Full Text] [Related]
9. Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders. McTavish D; Faulds D; Goa KL Drugs; 1990 Aug; 40(2):238-59. PubMed ID: 2226215 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy in the prevention of stroke. Easton JD Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215 [TBL] [Abstract][Full Text] [Related]
11. Ticlopidine: a new antiplatelet agent for cerebrovascular disease. Robert S; Miller AJ; Fagan SC Pharmacotherapy; 1991; 11(4):317-22; discussion 322-5. PubMed ID: 1923914 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients. Oster G; Huse DM; Lacey MJ; Epstein AM Stroke; 1994 Jun; 25(6):1149-56. PubMed ID: 8202972 [TBL] [Abstract][Full Text] [Related]
14. Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke. Noble S; Goa KL Drugs Aging; 1996 Mar; 8(3):214-32. PubMed ID: 8720746 [TBL] [Abstract][Full Text] [Related]
15. Ticlopidine hydrochloride use and threatened stroke. Rothrock JF; Hart RG West J Med; 1994 Jan; 160(1):43-7. PubMed ID: 8128701 [TBL] [Abstract][Full Text] [Related]
16. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease. Harbison JW Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798 [TBL] [Abstract][Full Text] [Related]
17. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. Bhatt DL; Kapadia SR; Yadav JS; Topol EJ Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181 [TBL] [Abstract][Full Text] [Related]
18. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. Tran H; Anand SS JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study. Bellavance A Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. Hass WK; Easton JD; Adams HP; Pryse-Phillips W; Molony BA; Anderson S; Kamm B N Engl J Med; 1989 Aug; 321(8):501-7. PubMed ID: 2761587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]